Shares of Genesco Inc. (NYSE:GCO - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the five research firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a strong buy rating on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $30.00.
Several analysts recently weighed in on GCO shares. Wall Street Zen upgraded shares of Genesco from a "hold" rating to a "buy" rating in a report on Saturday, October 11th. Seaport Res Ptn upgraded shares of Genesco from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. Weiss Ratings restated a "sell (d-)" rating on shares of Genesco in a report on Wednesday, October 8th. Zacks Research upgraded shares of Genesco from a "hold" rating to a "strong-buy" rating in a report on Friday, August 29th. Finally, Jefferies Financial Group boosted their target price on shares of Genesco from $24.00 to $29.00 and gave the company a "hold" rating in a report on Friday, August 29th.
Read Our Latest Stock Analysis on GCO
Genesco Stock Up 1.9%
Shares of Genesco stock opened at $29.21 on Thursday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.35 and a current ratio of 1.56. Genesco has a 52-week low of $16.19 and a 52-week high of $44.80. The stock has a market capitalization of $315.50 million, a price-to-earnings ratio of -11.97 and a beta of 2.27. The company's 50 day moving average price is $29.90 and its 200-day moving average price is $24.47.
Genesco (NYSE:GCO - Get Free Report) last issued its earnings results on Thursday, August 28th. The company reported ($1.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.25) by $0.11. Genesco had a negative net margin of 1.03% and a positive return on equity of 1.75%. The firm had revenue of $545.97 million for the quarter, compared to analysts' expectations of $531.89 million. During the same quarter last year, the business earned ($0.83) earnings per share. The business's revenue was up 4.0% on a year-over-year basis. Genesco has set its FY 2026 guidance at 1.300-1.700 EPS. Equities research analysts forecast that Genesco will post 0.94 EPS for the current year.
Institutional Trading of Genesco
Hedge funds have recently modified their holdings of the business. Jones Financial Companies Lllp bought a new stake in shares of Genesco during the 1st quarter valued at $26,000. CWM LLC boosted its stake in Genesco by 61.5% in the 2nd quarter. CWM LLC now owns 1,365 shares of the company's stock worth $27,000 after purchasing an additional 520 shares in the last quarter. Virtus Advisers LLC bought a new position in Genesco in the 1st quarter worth about $56,000. AlphaQuest LLC boosted its stake in Genesco by 501,200.0% in the 1st quarter. AlphaQuest LLC now owns 5,013 shares of the company's stock worth $106,000 after purchasing an additional 5,012 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in Genesco by 37.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,514 shares of the company's stock worth $109,000 after purchasing an additional 1,499 shares in the last quarter. Institutional investors own 94.51% of the company's stock.
Genesco Company Profile
(
Get Free Report)
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genesco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genesco wasn't on the list.
While Genesco currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.